Good manufacturing practice production of an off-the-shelf CD34(+) progenitor-derived NK cell product with preserved anti-tumor functionality post-infusion in NOD/SCID/IL2Rg(null) mice.
按照良好生产规范生产现成的 CD34(+) 祖细胞衍生 NK 细胞产品，该产品在输注到 NOD/SCID/IL2Rg(null) 小鼠后仍保持抗肿瘤功能
期刊:Cellular and Molecular Life Sciences
影响因子:6.2
doi:10.1007/s00018-025-05727-4
Hooijmaijers Laura, Vidal-Manrique Marcos, Spils Bart, van Ens Diede, Rodriguez Verónica Castaño, Hobo Willemijn, de Goede Anna L, van Dorp Suzanne, Jansen Joop H, van der Waart Anniek B, de Jonge Paul K J D, Dolstra Harry
